One Brand-new Maneuver to Place Nasoenteric Tube

Overview

Naso-enteric tube feeding is necessary for certain patients. Many methods are used to place a naso-enteric tube, such as bed-side blind method, fluoroscopy method and guide-wire method. INvestigators aim to introduce a safe, non-expensive and fast method to insert a silicon naso-gastric (NG) tube into the small intestine.

Full Title of Study: “Tzu-chi General Hospital,Hualien County,Taiwan,ROC”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 31, 2020

Detailed Description

Investigators tied a 1-cm surgical suture at the tip of a 16 French silicon NG tube (120 cm long, cost 5 US dollars). One conventional EGD (diameter 2.8 mm) biopsy forceps was inserted into the lumen as a strengthened stylet. Then investigators inserted a biopsy forceps (diameter 2.0 mm) and protruded a little out of the working channel of an ultrathin EGD scope (Fujinon EG 530 N, diameter 5.9 mm) to grasp the suture. The ultrathin EGD and NG tube were parallelly pushed into a selected nostril after adequate decongestive anesthesia (Epinephrine 0.3% + Lidocaine 5%) into the small intestine as deep as possible to the jejunum. Being placed to the small intestine as far as possible, the NG tube was released and the ultrathin EGD scope withdrew. When the scope was pulled backwards from the stomach, the shape/layout of a NG-tube could be simultaneously monitored and adjusted. At last, the EGD biopsy forceps (2.8 mm) inside the NG tube was removed. With this method, in real life, a plain film is not necessary to confirm the NG tube position. However, for study purpose, a KUB film was taken to check the NG tube position.

Interventions

  • Device: ultrathın esophagogastroduodenoscope
    • Place the naso-enteric tube together with the ultrathin esophagogastroduodenoscope from the same nasal cavity

Arms, Groups and Cohorts

  • Other: Naso-enteric tube placement
    • The participants needed nutrition from naso-enteric tube feeding are enrolled into this study. Double-blind was not needed here.

Clinical Trial Outcome Measures

Primary Measures

  • procedure time
    • Time Frame: wıthın 20 mınutes
    • The procedure times to place the tube are recorded

Secondary Measures

  • the tıme of naso-enterıc tube usage
    • Time Frame: within 90 days
    • The tıme of the naso-enteric tube was recorded in day

Participating in This Clinical Trial

Inclusion Criteria

1. Esophageal obstruction 2. Gastric outlet obstruction 3. Duodenal obstruction 4. Pancreatitis 5. Gastroparesis - Exclusion Criteria:

  • (1)Coagulopathy (2)Deviation of nasal septa (3)Conscious disturbance

Gender Eligibility: All

Minimum Age: 20 Years

Maximum Age: 90 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Buddhist Tzu Chi General Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Jen-Shung Lin, Prıncıpal ınvestıgator – Buddhist Tzu Chi General Hospital
  • Overall Official(s)
    • Jen S Lin, VS, Study Director, Buddhist Tzu Chi General Hospital
  • Overall Contact(s)
    • Jen S Lin, VS, 886-3-8561825, labyrinth68306830@icloud.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.